This content is current only at the time of printing. This document was printed on 5 December 2021. A current copy is located at https://apvma.gov.au/node/53236
Print this page
You are here
Special Gazette, 21 August 2019
Contents
- Final Regulatory Decision for the reconsideration of methiocarb—4
- Reasons for the affirmation of approvals—6
- Annexure 1: Affirmed representative label components—9